Sanofi shares on Euronext Paris, however, dipped 1.8% from €87.52 ($99.85) to €85.91 ($98.18). Hudson also said that Sanofi still retained a “sizeable” capacity for further acquisitions.

French pharmaceutical company Sanofi said on Tuesday it was exploring opportunities for producing vaccines in Vietnam in cooperation with local partner Vietnam Vaccine Company (VNVC), which ...

Sanofi SAN 0.23% said it entered an agreement to acquire Vigil Neuroscience VIGL 0.00% for approximately $470 million, a deal that adds a new investigational treatment for Alzheimer’s disease to ...

Sanofi stated that its investment decisions “will be adjusted as the external environment continues to evolve”. In 2024, $21.6bn of its $45.2bn global sales came from the US market.

Sanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment includes a significant increase in research and development spending ...

Sanofi has agreed to pay up to $465 million in milestones for exclusive rights to the latest program. The potential paydays add to the $1.9 billion that Nurix was eligible for at the end of November.

Sanofi's revenue was lower than AbbVie's, amounting to about $10.99 billion in the fourth quarter of 2024, down 7.4% year-on-year and 24.3% quarter-on-quarter. Why did its revenue drop so sharply?

Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top 10 drugs in global sales — early next year. It’s unclear how ...

The Glycerin Max will help athletes elevate their running journey with cutting-edge cushion technology to make every step feel effortless. A high stack of all-new, nitrogen-infused DNA Tuned in ...

A commonly found skin condition, eczema can affect both adults and children. In a March 2022 summit in Dubai, organised by Sanofi Greater Gulf and attended by over 200 dermatologists, doctors ...

Sanofi Healthcare India Pvt. Ltd. (SHIPL) on Wednesday announced the expansion of its Global Capacity Centre (GCC) in Hyderabad, with plans to invest €400 million over the next six years, with ...

Sanofi is implementing an accelerated growth plan, ‘India for India’ to gear up for the future and strengthen its India footprint, Rodolfo Hrosz, the company’s managing director said.